Table 4.
Pearson product-moment analysis of correlations between lymphocyte expression of intracellular cytokines and CD4+CD25+FOXP3+ cells in All type 2 diabetes patients (T2DM), CHD-afflicted T2DM, and in healthy control subjects.
| IFN-ϒ | TNF-α | IL-8 | IL-6 | IL-1β | |
|---|---|---|---|---|---|
| All T2DM | |||||
| CD4+IL-17+ cells | r = − 0.173 | r = − 0.072 | r = 0.309* | r = 0.256 | r = 0.358* |
| CD4+CD25+FOXP3+ cells | r = − 0.096 | r = − 0.189 | r = 0.143 | r = 0.276* | r = 0.308* |
| CD4+CD25+FOXP3+/Th1 cells | r = − 0.333** | r = −0.234 | r = 0.249 | r = − 0.188 | r = 0.186 |
| T2DM with CHD | |||||
| CD4+IL-17+ cells | r = 0.362 | r = 0.189 | r = 0.699 | r = 0.706 | r = 0.842* |
| CD4+CD25+FOXP3+ cells | r = 0.079 | r = 0.385 | r = 0.558 | r = 0.603* | r = 0.770 |
| CD4+CD25+FOXP3+/Th1 cells | r = −0.658* | r = − 0.441 | r = 0.361 | r = − 0.181 | r = 0.176 |
| T2DM without CHD | |||||
| CD4+IL-17+ cells | r = 0.370* | r = − 0.122 | r = 0.261 | r = 0.175 | r = 0.318* |
| CD4+CD25+FOXP3+ cells | r = 0.175 | r = 0.077 | r = − 0.122 | r = 0.190 | r = 0.028 |
| CD4+CD25+FOXP3+/Th1 cells | r = − 0.317* | r = − 0.212 | r = 0.269 | r = − 0.177 | r = − 0.072 |
| Healthy control | |||||
| CD4+IL-17+ cells | r = 0.640* | r = 0.595* | r = 0.164 | r = 0.849** | r = 0.652** |
| CD4+CD25+FOXP3+ cells | r = 0.385 | r = − 0.007 | r = 0.453 | r = 0.698** | r = 0.575* |
| CD4+CD25+FOXP3+/Th1 cells | r = −0.539* | r = −0.726** | r = − 0.223 | r = − 0.139 | r = − 0.210 |
*Significant direct or inverse correlation (P < 0.05) and **significant direct or inverse correlation (P < 0.01).